ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10069	Companies
205843	Keywords
136106	Articles
109146	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/22/2025 at 22:05, 11 months 1 day ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle pour le 6 juin 2025 à Paris, alors que la Société se rapproche d'étapes clés en 2025

Biotechnologie Abivax Assemblée Générale Annuelle Phase 3 Mécanismes De Régulation
PRESS RELEASE

published on 04/22/2025 at 22:05, 11 months 1 day ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle et se rapproche d'étapes clés créatrices de valeur en 2025. Essais cliniques ABTECT de phase 3 en progression

Abivax Étapes Clés Assemblée Générale Annuelle Phase 3 ABTECT
BRIEF

published on 04/22/2025 at 22:05, 11 months 1 day ago

Abivax welcomes Dr. Dominik Höchli to its Board of Directors

Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
BRIEF

published on 04/22/2025 at 22:05, 11 months 1 day ago

Abivax accueille le Dr Dominik Höchli au sein de son Conseil d’administration

Abivax Conseil D'administration Phase 3 Immunologie Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:05, 11 months 1 day ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials

Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE

published on 04/22/2025 at 22:00, 11 months 1 day ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax nomme le Dr Dominik Höchli au Conseil d’administration pour renforcer son expertise en immunologie avant la publication des données clés de l’étude de phase 3 dans la rectocolite hémorragique en 2025

Abivax Conseil D'administration Rectocolite Hémorragique Immunologie Dr Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:00, 11 months 1 day ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d'administration. Expert en immunologie, son arrivée renforce l'équipe à l'approche de la publication des données clés de l'étude de phase 3

Abivax Conseil D'administration Nomination Immunologie Données De Phase 3
PRESS RELEASE

published on 04/22/2025 at 22:00, 11 months 1 day ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025

Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF

published on 04/18/2025 at 18:05, 11 months 5 days ago

ABIVAX : Capital Social et Droits de Vote au 31 Mars 2025

Euronext Paris Droits De Vote Capital Social Actions Abivax
BRIEF

published on 04/18/2025 at 18:05, 11 months 5 days ago

ABIVAX: Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Actions Abivax

Accesswire

Published on 03/23/2026 at 22:00, 12 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 54 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 8 hours 7 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 8 hours 12 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 9 hours 7 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 22:05, 6 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 1 hour 7 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 1 hour 7 minutes ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 1 hour 11 minutes ago

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 1 hour 16 minutes ago

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Les Echos

Published on 03/23/2026 at 19:08, 3 hours 3 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 3 hours 3 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 3 hours 34 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 4 hours 26 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 4 hours 26 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE